2.5
2025

Is Tezepelumab the treatment option of choice in severe allergic asthma?

Show more: Authors information and Publication history
Authors Information

1Pulmonology Unit ASST Rhodense Garbagnate Milanese Hospital, Milan, Italy
2SOSD Allergy and Immunology Firenze Empoli, USL Toscana Centro, Italy

History

Published: 05 May 2025
Accepted: 08 April 2025
Received: 22 December 2024

KEY WORDS
Tezepelumab; allergic asthma; allergy.

Table of Content: Online First

European Annals of Allergy and Clinical Immunology | ©2026
Online ISSN: 2845-7285 (since 2024) · Print ISSN: 1764-1489 (discontinued in 2023)